Pierre Gagnon
Plus aucun poste en cours
Fortune : - $ au 30/04/2024
Profil
Mr. Pierre Gagnon is a Chief Operating Officer at NKGen Biotech, Inc. He is on the Board of Directors at ATGen Canada, Inc. Mr. Gagnon was previously employed as a Chief Operating Officer by NKGen Biotech, Inc. /US/ and a Director-Global Operations & Director by NKMAX Co., Ltd.
He received his undergraduate degree from the University of Quebec.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
-.--% | 29/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Pierre Gagnon
Sociétés | Poste | Début |
---|---|---|
ATGen Canada, Inc. | Directeur/Membre du Conseil | 01/05/2013 |
Anciens postes connus de Pierre Gagnon
Sociétés | Poste | Fin |
---|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Directeur des opérations | 01/09/2023 |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Directeur des opérations | 01/06/2019 |
Formation de Pierre Gagnon
University of Quebec | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |
ATGen Canada, Inc. |